Amgen : AMGN

All Amgen Articles

699 Articles

Jon C. Ogg | Dec 22, 2010 at 8:20 AM EST

Top Analyst Upgrades and Downgrades (ABB, AKAM, AMGN, CCL, GOL, RHT, SUN, SVU, THC, TIBX, TSL, UNH, YGE, YRCW)

These are some of this Wednesday’s key analyst upgrades, downgrades, and initiations seen in Wall Street research calls. ABB Ltd.…

Jon C. Ogg | Dec 17, 2010 at 8:20 AM EST

Top Analyst Upgrades and Downgrades (AMGN, AON, AMAT, ATML, CBS, CMA, CY, GIS, JNPR, LEA, ORCL, RIMM, LUV, VFC, V)

These are some of this Friday’s key analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Amgen Inc.…

Douglas A. McIntyre | Dec 15, 2010 at 4:59 AM EST

China Passes Japan In R&D, But Which Country Is Smarter?

The Battelle Memorial Institute, which looks at R&D in major nations, says that China will pass Japan as the No.2…

Jon C. Ogg | Dec 14, 2010 at 8:17 AM EST

Top Analyst Upgrades and Downgrades (AMGN, T, BCSI, BP, CMCSA, COP, EMC, XOM, IGT, NTAP, Q, S, TSO, TSL, VZ, VMW)

These are some of this Tuesday’s key analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Amgen Inc.…

Jon C. Ogg | Dec 7, 2010 at 8:08 AM EST

Top Analyst Upgrades and Downgrades (AMGN, AZN, BIIB, CELG, GSK, GFI, HGSI, LDK, MWV, NVS, RHT, RIMM, STX, SFD, STP, TIN, TSL, WDC)

These are some of this Tuesday’s key analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Amgen Inc.…

Jon C. Ogg | Nov 6, 2010 at 12:07 PM EDT

Stock Gains Skipping Biotech (GENZ, CELG, GILD, AMGN, BIIB, ALXN, MNKD, HGSI, VVUS, DNDN, BBH, XBI, QQQQ)

Biotech and emerging pharma both seem to have almost no friends today despite a large stock market rally. It may…

Jon C. Ogg | Oct 22, 2010 at 12:56 PM EDT

Next Week’s Must See Earnings (AMGN, CIT, DD, X, CMCSA, COP, PG, MMM, DOW, XOM, POT, FSLR, MSFT, CVX, MRK)

Earnings season is in full swing and the peak will occur next week. We have several DJIA components reporting earnings…

Jon C. Ogg | Sep 9, 2010 at 1:57 PM EDT

BioHealth Business Daily, Major News Breaks (QCOR, DNDN, GERN, STEM, ASTM, CYTX, NBS, BTIM, PSTI, SVA, VVUS, OREX, ARNA, SNTS, GENZ, SNY, TEVA, AMGN, ACOR, CELG, HGSI, BIIB, GILD, EXAS, ZGEN, DYAX, IDXX, VPHM)

Biotech and BioHealth stocks are on the move today and there is more news in the emerging sector than there…

Jon C. Ogg | Sep 9, 2010 at 8:24 AM EDT

Top Analyst Upgrades and Downgrades (AMGN, AU, BP, BIIB, CELG, GILD, HMY, HGSI, LYG, MPEL, MVIS, RIMM, TEVA, VPHM, WBD)

These are some of this Thursday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls: Amgen Inc.…

Jon C. Ogg | Aug 9, 2010 at 8:01 AM EDT

Genzyme Needs to Update Its Merger Status (GENZ, SNY, PFE, AMGN, JNJ)

Genzyme Corporation (NASDAQ: GENZ) still has an incredible merger ‘deal premium’ associated with it over a pending Sanofi-Aventis (NYSE: SNY)…

Jon C. Ogg | Jul 23, 2010 at 2:15 PM EDT

Looking at Genzyme’s Peers for ‘Other Buyout Candidate’ Probabilities (GENZ, SNY, GILD, CELG, BIIB, LIFE, HGSI, DNDN)

Genzyme Corporation (NASDAQ: GENZ) is flying high on reports that Sanofi-Aventis (NYSE: SNY) may have an interest in buying the…

Jon C. Ogg | Jul 7, 2010 at 1:21 PM EDT

BioHealth Business Daily (AMGN, SNY, AFFX, CORT, CRIS, CYTR, HGSI, NEXMD, NYMX, XNPT)

Today’s version of the BioHealth Business Daily is a very unusual lot of movers. Some moves are merely in sympathy…

Jon C. Ogg | Jul 6, 2010 at 2:24 PM EDT

More Big Drug & Biotech Mergers Likely (SNY, AMGN, BIIB, GENZ, BSX, JNJ, HGSI, DNDN, AUXL, VRTX, AMLN, LLY, WCRX, CBST)

Sanofi-Aventis SA (NYSE: SNY) was a bit of a stalking horse news item on a week that many investors and…

Jon C. Ogg | Jun 18, 2010 at 2:37 PM EDT

BioHealth Business Daily (AMGN, AMLN, ALKS, DNDN, SNY, GENZ, MIPI)

There are many key movers in today’s BioHealth Business Daily. We have included background data, news, reactions, and added in…

Jon C. Ogg | Jun 2, 2010 at 2:17 PM EDT

Opportunity Knocks: Turning Around 3 Large Biotechs (AMGN, BIIB, GENZ)

Biotech is the land of promise for emerging players. It is also the land of stagnation for well established and…

1 … 38 39 40 41 42 … 47

Amgen : AMGN

All Amgen Articles

Top Analyst Upgrades and Downgrades (ABB, AKAM, AMGN, CCL, GOL, RHT, SUN, SVU, THC, TIBX, TSL, UNH, YGE, YRCW)

Top Analyst Upgrades and Downgrades (AMGN, AON, AMAT, ATML, CBS, CMA, CY, GIS, JNPR, LEA, ORCL, RIMM, LUV, VFC, V)

China Passes Japan In R&D, But Which Country Is Smarter?

Top Analyst Upgrades and Downgrades (AMGN, T, BCSI, BP, CMCSA, COP, EMC, XOM, IGT, NTAP, Q, S, TSO, TSL, VZ, VMW)

Top Analyst Upgrades and Downgrades (AMGN, AZN, BIIB, CELG, GSK, GFI, HGSI, LDK, MWV, NVS, RHT, RIMM, STX, SFD, STP, TIN, TSL, WDC)

Stock Gains Skipping Biotech (GENZ, CELG, GILD, AMGN, BIIB, ALXN, MNKD, HGSI, VVUS, DNDN, BBH, XBI, QQQQ)

Next Week’s Must See Earnings (AMGN, CIT, DD, X, CMCSA, COP, PG, MMM, DOW, XOM, POT, FSLR, MSFT, CVX, MRK)

BioHealth Business Daily, Major News Breaks (QCOR, DNDN, GERN, STEM, ASTM, CYTX, NBS, BTIM, PSTI, SVA, VVUS, OREX, ARNA, SNTS, GENZ, SNY, TEVA, AMGN, ACOR, CELG, HGSI, BIIB, GILD, EXAS, ZGEN, DYAX, IDXX, VPHM)

Top Analyst Upgrades and Downgrades (AMGN, AU, BP, BIIB, CELG, GILD, HMY, HGSI, LYG, MPEL, MVIS, RIMM, TEVA, VPHM, WBD)

Genzyme Needs to Update Its Merger Status (GENZ, SNY, PFE, AMGN, JNJ)

Looking at Genzyme’s Peers for ‘Other Buyout Candidate’ Probabilities (GENZ, SNY, GILD, CELG, BIIB, LIFE, HGSI, DNDN)

BioHealth Business Daily (AMGN, SNY, AFFX, CORT, CRIS, CYTR, HGSI, NEXMD, NYMX, XNPT)

More Big Drug & Biotech Mergers Likely (SNY, AMGN, BIIB, GENZ, BSX, JNJ, HGSI, DNDN, AUXL, VRTX, AMLN, LLY, WCRX, CBST)

BioHealth Business Daily (AMGN, AMLN, ALKS, DNDN, SNY, GENZ, MIPI)

Opportunity Knocks: Turning Around 3 Large Biotechs (AMGN, BIIB, GENZ)

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

This Dividend ETF Is up 30% in 6 Months With a 3.7% Dividend Yield

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Amgen : AMGN

All Amgen Articles

Top Analyst Upgrades and Downgrades (ABB, AKAM, AMGN, CCL, GOL, RHT, SUN, SVU, THC, TIBX, TSL, UNH, YGE, YRCW)

Top Analyst Upgrades and Downgrades (AMGN, AON, AMAT, ATML, CBS, CMA, CY, GIS, JNPR, LEA, ORCL, RIMM, LUV, VFC, V)

China Passes Japan In R&D, But Which Country Is Smarter?

Top Analyst Upgrades and Downgrades (AMGN, T, BCSI, BP, CMCSA, COP, EMC, XOM, IGT, NTAP, Q, S, TSO, TSL, VZ, VMW)

Top Analyst Upgrades and Downgrades (AMGN, AZN, BIIB, CELG, GSK, GFI, HGSI, LDK, MWV, NVS, RHT, RIMM, STX, SFD, STP, TIN, TSL, WDC)

Stock Gains Skipping Biotech (GENZ, CELG, GILD, AMGN, BIIB, ALXN, MNKD, HGSI, VVUS, DNDN, BBH, XBI, QQQQ)

Next Week’s Must See Earnings (AMGN, CIT, DD, X, CMCSA, COP, PG, MMM, DOW, XOM, POT, FSLR, MSFT, CVX, MRK)

BioHealth Business Daily, Major News Breaks (QCOR, DNDN, GERN, STEM, ASTM, CYTX, NBS, BTIM, PSTI, SVA, VVUS, OREX, ARNA, SNTS, GENZ, SNY, TEVA, AMGN, ACOR, CELG, HGSI, BIIB, GILD, EXAS, ZGEN, DYAX, IDXX, VPHM)

Top Analyst Upgrades and Downgrades (AMGN, AU, BP, BIIB, CELG, GILD, HMY, HGSI, LYG, MPEL, MVIS, RIMM, TEVA, VPHM, WBD)

Genzyme Needs to Update Its Merger Status (GENZ, SNY, PFE, AMGN, JNJ)

Looking at Genzyme’s Peers for ‘Other Buyout Candidate’ Probabilities (GENZ, SNY, GILD, CELG, BIIB, LIFE, HGSI, DNDN)

BioHealth Business Daily (AMGN, SNY, AFFX, CORT, CRIS, CYTR, HGSI, NEXMD, NYMX, XNPT)

More Big Drug & Biotech Mergers Likely (SNY, AMGN, BIIB, GENZ, BSX, JNJ, HGSI, DNDN, AUXL, VRTX, AMLN, LLY, WCRX, CBST)

BioHealth Business Daily (AMGN, AMLN, ALKS, DNDN, SNY, GENZ, MIPI)

Opportunity Knocks: Turning Around 3 Large Biotechs (AMGN, BIIB, GENZ)

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

This Dividend ETF Is up 30% in 6 Months With a 3.7% Dividend Yield

Featured Reads

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It